Summit Clinical Research

11/10/2025

It’s been an exciting few days of connecting with colleagues, engaging in meaningful scientific discussions, and learning from leading experts in liver research.

Exciting to see Mazen Noureddin, MD, MHSc, FAASLD and Naim Alkhouri, MD, FAASLD leading the charge in advancing liver disease research and clinical innovation while attending The Liver Meeting® 2025, hosted by AASLD!

The Summit Center of Learning team is proud to participate in discussions that highlight the latest advances in liver disease research and clinical practice.

American Association for the Study of Liver Diseases (AASLD) Summit Clinical Research Pinnacle Clinical Research Gail Hinkson S. Brandon Early Genevieve Long

11/09/2025

Naim Alkhouri, MD, FAASLD will share new data on the longitudinal progression of biomarker and imaging endpoints in MASLD while attending The Liver Meeting® 2025.

Two-year time course of biomarker and imaging responses in well-compensated MASH cirrhosis patients treated with resmetirom

Sunday, November 9th | 5:30 PM EST | Ballroom A, Level 3 | Walter E. Washington Convention Center

Join this discussion to gain new perspectives on disease progression and the role of biomarkers and imaging in understanding MASLD. The findings presented will offer practical applications for both clinical and research settings. Don’t miss the opportunity to learn from and connect with experts contributing to the advancement of liver disease science.

American Association for the Study of Liver Diseases (AASLD) Mazen Noureddin, MD, MHSc, FAASLD Naim Alkhouri, MD, FAASLD Rashmee Patil, MD Summit Clinical Research Pinnacle Clinical Research

11/09/2025

Through Summit Center of Learning, we’re proud to support collaboration, scientific communication, and education in liver research.

While attending The Liver Meeting® 2025, hosted by AASLD, Beth Brombosz, PhD Medical Writer with Summit Center of Learning, will be available to connect and discuss Summit’s medical writing and scientific initiatives.

If you’re interested in learning more about Summit Center of Learning’s capabilities, connect with Beth!

American Association for the Study of Liver Diseases (AASLD) Mazen Noureddin, MD, MHSc, FAASLD Naim Alkhouri, MD, FAASLD Rashmee Patil, MD Summit Clinical Research Pinnacle Clinical Research

S. Brandon Early Genevieve LongMadrigal Pharmaceuticals Ipsen Novo Nordisk

11/07/2025

Summit Clinical Research is proud to recognize the leaders advancing innovation in liver disease research and education.

While attending The Liver Meeting® 2025, Rashmee Patil will share new perspectives on the evolving landscape of liver disease research and clinical practice.

We’re honored to support experts who exemplify Summit’s mission to advance science and improve patient outcomes.



American Association for the Study of Liver Diseases (AASLD) Mazen Noureddin, MD, MHSc, FAASLD Naim Alkhouri, MD, FAASLD Rashmee Patil Summit Clinical Research Pinnacle Clinical Research Gail Hinkson S. Brandon Early Madrigal Pharmaceuticals Novo Nordisk Ipsen

11/07/2025

Through Summit Clinical Research, we’re proud to highlight our expert collaborators who continue shaping the conversation in liver disease research.

While attending The Liver Meeting® 2025, Dr. Mazen Noureddin will share new data and insights that advance our understanding of steatotic liver disease and its management.

Summit remains dedicated to fostering collaboration, education, and innovation across the global research community.

AASLD

American Association for the Study of Liver Diseases (AASLD) Naim Alkhouri, MD, FAASLD Mazen Noureddin, MD, MHSc, FAASLD Rashmee Patil Pinnacle Clinical Research Summit Clinical Research S. Brandon Early Genevieve Long Gail Hinkson Madrigal Pharmaceuticals Novo Nordisk Ipsen

11/06/2025

At Summit Clinical Research, we celebrate the investigators driving progress in liver disease research and patient care.

While attending American Association for the Study of Liver Diseases (AASLD) Liver Meeting® 2025, Dr. Naim Alkhouri will present new insights into improving the diagnosis and treatment of metabolic dysfunction–associated steatotic liver disease (MASLD).

AASLD

Summit is proud to collaborate with leaders whose work continues to move the field forward.

Naim Alkhouri, MD, FAASLD Mazen Noureddin, MD, MHSc, FAASLD Rashmee Patil Pinnacle Clinical Research Summit Clinical Research
S. Brandon Early Genevieve Long Gail Hinkson Madrigal Pharmaceuticals Novo Nordisk Ipsen

09/26/2025

Through Summit Center of Learning, we host preceptorship programs that bring together leading experts, clinical teams, and site staff to share knowledge and practical insights in liver disease.

These immersive sessions go beyond presentations - they create space for dialogue, collaboration, and firsthand understanding of how clinical research happens on the ground.

It’s one of the ways Summit is working to advance education and strengthen clinical research across therapeutic areas.

Learn more: https://summitclinicalresearch.com/

07/21/2025

Through July 18, Summit has screened 3,180 participants and randomized 901 across active liver and metabolic studies. That’s a 28 percent screen-to-randomization rate, which is well above typical performance for complex liver and metabolic trials.

We’ve hit as many as 62 randomizations in a single week, and we’re seeing that level of performance more than once.

These results reflect the strength of our site network, the consistency of our teams, and the focus we bring to every trial we support.

07/14/2025

is a KOL-led Integrated Research Organization focused on liver, metabolic, and neurodegenerative diseases.

We combine deep scientific expertise with scalable operational services to accelerate clinical trials that matter.

From protocol design to site activation and patient recruitment, we help sponsors move faster, smarter, and with greater confidence.

Ready to accelerate your next trial? Learn more at https://summitclinicalresearch.com/

07/11/2025

✈️ Next stop: Boston.

Summit Clinical Research is heading to the Obesity & Weight Loss Drug Development Summit as an Innovation Partner and can’t wait to connect.

Our booth will also feature members of the team from Pinnacle Clinical Research. Stop by Booth #2 and say hello. We’re looking forward to conversations that move obesity research forward.

📅 July 14–16 | 📍 Booth #2

https://lnkd.in/dfvvG26W

07/08/2025

Boston, we’re coming your way!

Summit Clinical Research is attending the Obesity & Weight Loss Drug Development Summit next week, and we’re excited to connect with industry leaders shaping the future of obesity care.

Attending on our behalf:

• Dave Rosa, Director of Business Development

• Our site partners at Pinnacle Clinical Research:
• Dr. Rashmee Patil, CEO & Hepatologist
• Dr. Dimple Desai, PI & South Texas Medical Director (Brownsville)
• Dan Duffy, CEO

📍 Visit us at Booth #2 and say hello.

📅 July 14–16 | Boston, MA
https://obesity-weight-loss-summit.com/

Companies Attending Include: Harnessing Novel Targets & GLP Combination Therapies to Improve Efficacy & Tolerability for Longer Lasting Clinical Outcomes EVENT GUIDE REGISTER PARTNER Advancing Best-In Class Weight Loss Therapies in the Evolving Obesity Landscape The 3rd Obesity & Weight Loss Drug De...

07/04/2025

From all of us at Summit Clinical Research — Happy Fourth of July.
Hope you get a chance to relax, recharge, and enjoy the day with the people who matter most.